Alnylam Pharmaceuticals
The Associate Director of Regulatory Affairs Strategy leads regulatory strategy for assigned programs, facilitating submissions to the US FDA and international health agencies. This role serves as the US Regional Lead for early pipeline programs, guiding regulatory strategy and representing Regulatory Affairs on multidisciplinary teams. The position involves planning and coordinating all aspects of regulatory submissions to support product development, clinical trials, and product registration.
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Alnylam Pharmaceuticals.
Associate Director of Regulatory Affairs Strategy
alnylam
Senior Director of Regulatory Affairs
Latigobio
Vice President, US Regulatory Affairs
ITF Therapeutics
Senior Manager, Regulatory Affairs
Transforming Hypertrophic Cardiomyopathy Care
Regulatory Affairs Manager, CMC & Clinical Development
Harrow, Inc.
Senior Director, Regulatory Affairs
BeOne Medicines